Agilent Technologies Inc

NYSE A

Data sourced from

and

Daily

Download Data

Agilent Technologies Inc Price to FCFE Ratio (P/FCFE) on June 03, 2024

Agilent Technologies Inc Price to FCFE Ratio (P/FCFE) is NA on June 03, 2024, a NA change year over year. The price to free cash flow to equity (FCFE) ratio compares the market price per share of a company's stock to its free cash flow available to equity holders. It is calculated by dividing the market capitalization by the free cash flow minus the difference between capital expenditures and net acquisitions, divided by the number of outstanding shares. This ratio provides insights into the market's valuation of a company's FCFE generation. A higher ratio suggests that investors are willing to pay a higher price for each unit of free cash flow available to equity holders, indicating positive market sentiment.

Agilent Technologies Inc 52-week high Price to FCFE Ratio (P/FCFE) is NA on June 03, 2024, which is NA below the current Price to FCFE Ratio (P/FCFE).
Agilent Technologies Inc 52-week low Price to FCFE Ratio (P/FCFE) is NA on June 03, 2024, which is NA below the current Price to FCFE Ratio (P/FCFE).
Agilent Technologies Inc average Price to FCFE Ratio (P/FCFE) for the last 52 weeks is NA.

NYSE: A

Agilent Technologies Inc

CEO	Mr. Michael R. McMullen
IPO Date	Nov. 18, 1999
Location	United States
Headquarters	5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051
Employees	18,000
Sector	Healthcare
Industry	Diagnostics & research

Description

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Key trends